Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Molecular Diagnostics
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
The lack of a genetic driver of metastatic cancer has led researchers to look for other causes of disease progression.
March 23, 2023
Mailing HPV self-sampling kits for cervical cancer screening was cost-effective in study
The study, published Wednesday in JAMA Network Open, supports mailing HPV kits as an efficient outreach strategy for increasing screening rates among eligible women.
March 22, 2023
Guardant Health, Ohio State University study colorectal cancer screening adherence
The Ohio State University-led study will evaluate changes in CRC screening adherence in underserved urban and rural communities. Guardant Health is providing its Shield blood test to eligible individuals through mobile health clinic partners.
March 21, 2023
Invitae partners with Epic on workflow for genetic testing results
Invitae will make its genetic tests results available through Aura in the usual workflows of providers in Epic’s community.
March 21, 2023
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
People who recover from SARS-CoV-2 infection and then get vaccinated are more protected than people who are unvaccinated, the researchers added.
March 20, 2023
Genetic causes identified for three rare diseases
A computational approach helped identify previously unknown genetic causes of primary lymphedema, thoracic aortic aneurysm disease, and congenital deafness.
March 16, 2023
Most Popular
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
Patients prefer immediate test results, even when the news is bad
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Researchers in Spain demonstrate HCV RNA detection, genotyping using dried blood spot samples
The research shows the potential of using dried blood spot samples for determining cure rates and differentiating between reinfection and relapse after antiviral treatment in people who inject drugs.
March 20, 2023
Molecular test in study identified hypnotizable patients for postoperative pain treatment
A molecular point-of-care test identified individuals for whom hypnosis may relieve postoperative pain, potentially reducing opioid use.
March 15, 2023
Bionano Laboratories launches new optical genome mapping tests
These tests offer genome-wide assessment of structural variants (SVs) and testing for most common and rare chromosomal abnormalities to assist clinicians in both diagnosing and managing their patients’ medical conditions.
March 15, 2023
Netherlands researchers combine CRISPR, bioluminescence in proof-of-concept infectious disease test
Glow-in-the-dark proteins, developed from the luciferase found in bioluminescent creatures, may make viral disease diagnosis quicker and easier, according to the researchers.
March 15, 2023
Sophia Genetics partnering with Agilent Technologies to offer cancer analysis solution
Through the partnership, the Sophia DDM Platform will be integrated with Agilent’s research-use-only SureSelect Cancer Comprehensive Genomic Profiling (CGP) Assay Kit.
March 14, 2023
Long COVID less likely after Omicron than after original virus, Swiss researchers find
In a Swiss study, investigators have found that long COVID is less likely after Omicron infection than after infection by the original wild-type SARS-CoV-2 virus.
March 9, 2023
Page 1 of 173
Next Page
